Trinity Legacy Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.82M Buy
18,358
+1,105
+6% +$378K 1.36% 28
2026
Q1
$6.05M Sell
17,253
-73
-0.4% -$26K 1.31% 28
2025
Q4
$5.67M Buy
17,326
+273
+2% +$86.6K 1.3% 29
2025
Q3
$5.09M Buy
17,053
+743
+5% +$215K 1.17% 37
2025
Q2
$4.88M Buy
16,310
+178
+1% +$50.4K 1.18% 36
2025
Q1
$4.36M Buy
16,132
+612
+4% +$181K 1.1% 41
2024
Q4
$4.05M Buy
15,520
+138
+0.9% +$40.9K 1.04% 45
2024
Q3
$4.99M Buy
15,382
+239
+2% +$78.2K 1.28% 34
2024
Q2
$4.73M Buy
15,143
+87
+0.6% +$25.6K 1.35% 30
2024
Q1
$4.28M Buy
15,056
+2,289
+18% +$670K 1.25% 32
2023
Q4
$3.68M Buy
12,767
+36
+0.3% +$9.81K 1.16% 31
2023
Q3
$3.42M Buy
+12,731
New +$3.18M 1.18% 31
2022
Q3
Sell
-1,143
Closed -$283K 75
2022
Q2
$283K Hold
1,143
0.11% 80
2022
Q1
$276K Hold
1,143
0.09% 85
2021
Q4
$257K Buy
+1,143
New +$241K 0.09% 95

Other funds holding AMGN

Trinity Legacy Partners's AMGN Position: Q2 2026 in Review

Trinity Legacy Partners increased its Amgen (AMGN) stake by 6.4% in Q2 2026, buying an estimated $378K and bringing the position to 18,358 shares worth $6.82M. The position accounts for 1.36% of the portfolio, ranked #28.

Trinity Legacy Partners first reported a position in AMGN in Q4 2021 and has held it in 15 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Trinity Legacy Partners held 18,358 shares of Amgen worth $6.82M as of Q2 2026.
  • Trinity Legacy Partners bought 1,105 Amgen shares in Q2 2026, an estimated $378K.
  • Amgen made up 1.36% of Trinity Legacy Partners's portfolio in Q2 2026, its #28 holding.
  • Trinity Legacy Partners first reported a position in Amgen in Q4 2021 and has held it in 15 quarters since.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Trinity Legacy Partners's 13F filing for Q2 2026, filed 24 Jul 2026.